ETR:RHKRhoen Klinikum Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Rhoen Klinikum AG Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €18.14 +0.70 (+4.01 %) (As of 07/8/2020 04:01 AM ET) Add Compare Share Today's Range€17.40Now: €18.14▼€18.1950-Day Range€17.44MA: €18.14▼€18.4252-Week Range€14.14Now: €18.14▼€27.40Volume52,074 shsAverage Volume43,281 shsMarket Capitalization$1.21 billionP/E Ratio30.23Dividend Yield1.60%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlines RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases. As of December 31, 2018, it operated 11 hospitals and 5,369 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.Read More Beat the Market (BTM) Rank™ 0.8 Analyst's Opinion Consensus RatingRhoen Klinikum has received a consensus rating of Hold. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of €17.63, Rhoen Klinikum has a potential downside of 2.8% from its current price of €18.14.Amount of Analyst CoverageRhoen Klinikum has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Community Rank Outperform VotesRhoen Klinikum has received 138 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRhoen Klinikum has received 204 “underperform” votes. (Add your “underperform” vote.)Community SentimentRhoen Klinikum has received 59.65% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Rhoen Klinikum and other stocks. Vote “Outperform” if you believe RHK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RHK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend YieldRhoen Klinikum pays a meaningful dividend of 1.60%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthRhoen Klinikum does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Rhoen Klinikum is 48.33%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rhoen Klinikum insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Rhoen Klinikum are expected to decrease by -100.00% in the coming year, from €0.79 to €0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rhoen Klinikum is 30.23, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.72.Price to Earnings Ratio vs. SectorThe P/E ratio of Rhoen Klinikum is 30.23, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.43.Price to Earnings Growth RatioRhoen Klinikum has a PEG Ratio of 4.90. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioRhoen Klinikum has a P/B Ratio of 1.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.8Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.88 out of 5 stars Industry, Sector and Symbol Stock Exchange ETR Industry Medical Care Sub-IndustryN/A SectorMedical Current SymbolETR:RHK Previous Symbol CUSIPN/A CIKN/A Webwww.rhoen-klinikum-ag.com Phone+49-9-771650Debt Debt-to-Equity Ratio14.58 Current Ratio2.11 Quick Ratio1.96Price-To-Earnings Trailing P/E Ratio30.23 Forward P/E Ratio22.96 P/E Growth4.9 Sales & Book Value Annual Sales$1.49 billion Price / Sales0.82 Cash Flow€4.31 per share Price / Cash Flow4.21 Book Value€17.29 per share Price / Book1.05Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees9,384 Outstanding Shares66,938,500Market Cap$1.21 billion Next Earnings Date8/6/2020 (Estimated) OptionableNot Optionable RHK Rates by TradingView Receive RHK News and Ratings via Email Sign-up to receive the latest news and ratings for RHK and its competitors with MarketBeat's FREE daily newsletter. Rhoen Klinikum (ETR:RHK) Frequently Asked Questions How has Rhoen Klinikum's stock been impacted by COVID-19 (Coronavirus)? Rhoen Klinikum's stock was trading at €18.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RHK shares have increased by 0.6% and is now trading at €18.14. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Rhoen Klinikum? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rhoen Klinikum in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Rhoen Klinikum. When is Rhoen Klinikum's next earnings date? Rhoen Klinikum is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Rhoen Klinikum. What price target have analysts set for RHK? 4 brokers have issued 12-month price objectives for Rhoen Klinikum's stock. Their forecasts range from €16.50 to €18.00. On average, they expect Rhoen Klinikum's stock price to reach €17.63 in the next year. This suggests that the stock has a possible downside of 2.8%. View analysts' price targets for Rhoen Klinikum. Has Rhoen Klinikum been receiving favorable news coverage? Media coverage about RHK stock has been trending negative on Wednesday, InfoTrie reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rhoen Klinikum earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Rhoen Klinikum. Who are some of Rhoen Klinikum's key competitors? Some companies that are related to Rhoen Klinikum include Mediclinic International (MDC), CENTRIC HEALTH (CHH), Healius (HLS), CareTech (CTH), Spire Healthcare Group (SPI), Virtus Health (VRT), Pacific Smiles Group (PSQ), Georgia Healthcare Group (GHG), Sanara MedTech (SMTI), Assure (IOM), Totally (TLY), Konekt (KKT), Brain Resource (BRC), Nobilis Health (HLTH) and Wellness and Beauty (WNB). View all competitors. What other stocks do shareholders of Rhoen Klinikum own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rhoen Klinikum investors own include Seabridge Gold (SA), iShares Silver Trust (SLV), Walt Disney (DIS), Alamos Gold (AGI), Anova Metals (AWV), Bayerische Motoren Werke (BMW), Anheuser Busch Inbev (BUD), Cognex (CGNX), Canadian National Railway (CNI) and Discovery Inc Series C (DISCK). Who are Rhoen Klinikum's key executives? Rhoen Klinikum's management team includes the following people: Mr. Stephan Holzinger, Chairman of Board of Management & CEOProf. Bernd Griewing, Chief Medical Officer & Member of Board of ManagementDr. Gunther Karl Weiß, COO & Member of Management Board (Age 53)Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 67)Julian Schmitt, Head of Investor Relation What is Rhoen Klinikum's stock symbol? Rhoen Klinikum trades on the ETR under the ticker symbol "RHK." What is Rhoen Klinikum's stock price today? One share of RHK stock can currently be purchased for approximately €18.14. How big of a company is Rhoen Klinikum? Rhoen Klinikum has a market capitalization of $1.21 billion and generates $1.49 billion in revenue each year. Rhoen Klinikum employs 9,384 workers across the globe. What is Rhoen Klinikum's official website? The official website for Rhoen Klinikum is www.rhoen-klinikum-ag.com. How can I contact Rhoen Klinikum? Rhoen Klinikum's mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company can be reached via phone at +49-9-771650. This page was last updated on 7/8/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
